L01AA01 • cyclophosphamide • Antineoplastic and immunomodulating agents | Alkylating agents | Nitrogen mustard analogues
Cyclophosphamidum is a chemotherapy drug used to treat various types of cancer, including lymphomas, leukemias, and breast cancer. It belongs to the class of alkylating agents and works by destroying cancer cells and preventing them from dividing.
The medication is administered intravenously or orally, depending on the type and stage of cancer. It is often used in combination with other chemotherapy drugs to enhance treatment effectiveness.
Side effects may include nausea, vomiting, hair loss, fatigue, and an increased risk of infections. In rare cases, it may cause kidney or bladder toxicity. It is important to follow all medical recommendations to minimize risks.
Consult your doctor to discuss the benefits and risks of treatment with Cyclophosphamidum. Close monitoring is essential during treatment to manage potential side effects.
Substance: cyclophosphamide
Date of last drug list: 01-06-2025
Commercial code: W70297001
Concentration: 50mg
Pharmaceutical form: dragees
Quantity: 50
Product type: original
Price: 62.39 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: BAXTER ONCOLOGY GMBH - GERMANIA
Holder: BAXTER HEALTHCARE S.R.L. - ROMANIA
Number: 9095/2016/01
Shelf life: 3 years
Price
Copayment
Patient
62.39 RON
31.20 RON
31.20 RON
G17 (C1) - Major collagenosis (systemic lupus erythematosus, scleroderma)
Price
Copayment
Patient
62.39 RON
62.39 RON
0.00 RON
GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)
Price
Copayment
Patient
62.39 RON
62.39 RON
0.00 RON
NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant
Price
Copayment
Patient
62.39 RON
62.39 RON
0.00 RON